Fox Chase’s Cancer Genome Institute
July 19, 2011 | Terry Sharrer
Life Technologies, Inc. (Carlsbad, CA)-formed from a 2008 merger of Invitrogen Corporation and Applied Biosystems-has reached an agreement with the Fox Chase Cancer Center (Philadelphia) to deploy the next generation DNA sequencing machines in a major step to sub-classifying solid tumors for individuality. A new facility, known as the Cancer Genome Institute, will take advantage of the biorepository Fox Chase established as the first stem toward personalized medicine. MORE